As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

 11/9/23  PharmaCyte Biotech, Inc.          8-K:4       11/5/23   10:187K                                   GlobalOne Filings Inc/FA 
  8/4/23  PharmaCyte Biotech, Inc.          8-K:4,9      8/1/23   11:198K                                   GlobalOne Filings Inc/FA 
 11/2/15  PharmaCyte Biotech, Inc.          8-K:4,9    10/29/15    2:19K                                    Publicease Inc./FA       
 5/28/15‡ PharmaCyte Biotech, Inc.          8-K:4,9     5/26/15    2:27K                                    Publicease Inc./FA       
 2/29/12‡ PharmaCyte Biotech, Inc.          8-K/A:4,9    2/9/12    2:16K                                    Bollman Trisha M/FA      
 2/15/12  PharmaCyte Biotech, Inc.          8-K:4,9      2/9/12    2:15K                                    Bollman Trisha M/FA      
 3/29/10‡ PharmaCyte Biotech, Inc.          8-K/A:4,9    3/8/10    2:41K                                    Edgar Solutions Inc./FA  
  3/9/10  PharmaCyte Biotech, Inc.          8-K:4        3/8/10    1:12K                                    Bollman Trisha M/FA      
  7/2/07  PharmaCyte Biotech, Inc.          8-K/A:4     6/19/07    1:14K                                    Bollman Trisha M/FA      
 6/21/07  PharmaCyte Biotech, Inc.          8-K:4,9     6/19/07    2:48K                                    Dickson Rita S/FA        

____________
‡	A non-Insider-Ownership Filing that was accepted after the SEC “closed” at 5:30:00pm ET.  The legal “Filed As Of” date may be the next, or another, day.
¹	Filing/Form Type:  /A
	8-K	Current Report — Form 8-K { Item 1: Business & Operations;  2: Financial Info;  3: Securities & Trading;  4: Accountants & Accounting;  5: Governance & Management;  6: Asset-Backed Securities;  7: Disclosures;  8: Events;  9: Financials }.
	/A	Amendment to, or Amended version of, a previous Filing of this Type.